Marquette Asset Management’s Niagen Bioscience NAGE Stock Holding History
Bought
Maintained
Sold
Other funds holding NAGE
Marquette Asset Management's NAGE Position: Q3 2026 in Review
Marquette Asset Management opened a new position in Niagen Bioscience (NAGE) in Q3 2026: 446 shares worth $1.3K. The stake represents ﹤0.01% of the portfolio and ranks #615 among its holdings.
4 funds tracked by Wall St. Rank hold NAGE as of Q3 2026.
- Marquette Asset Management held 446 shares of Niagen Bioscience worth $1.3K as of Q3 2026.
- Niagen Bioscience was a new Marquette Asset Management position in Q3 2026.
- Niagen Bioscience made up ﹤0.01% of Marquette Asset Management's portfolio in Q3 2026, its #615 holding.
- 4 funds tracked by Wall St. Rank held Niagen Bioscience as of Q3 2026.
Based on Marquette Asset Management's 13F filing for Q3 2026, filed 9 Oct 2026.